New Managing Director for subsidiary Osstell
PRESS RELEASE
Gothenburg, Sweden, March 31, 2010
New Managing Director for Biolin Scientific’s subsidiary Osstell
Jonas Ohlsson has been appointed as the new Managing Director and President of Osstell AB.
Jonas Ohlsson has been appointed as the new Managing Director and President of Osstell AB. Jonas Ohlsson has had previous CEO assignments for more than 10 years in several international medtech and life science companies, focused on innovative technologies and products. Jonas Ohlsson has previously been working in companies such as Mentice and Applied Biosystems. Jonas Ohlsson succeeds Anders Peterson, who has been the managing director since year 2000. Anders Petersson will continue with Osstell in a new role, focusing on development and production activities.
”Jonas Ohlsson is a driven entrepreneur with a strong track record. We are convinced that he is the right person to lead Osstell, which is ready to increase its growth and focus on expansion. Anders Peterson has done an excellent job to create an innovative company with unique products.” says Fredrik Lindgren, CEO for Biolin Scientific.
”Osstell is an exciting company with the technology and products that brings opportunities for improved dental implant surgery. I am looking forward to being part of Osstell and to develop it further with sustainable and profitable growth. The company is well positioned for the future, following the focused and persistent efforts in product development and establishment of crucial key opinion leader relationships.” says Jonas Ohlsson, new Managing Director in Osstell.
For further information, please contact:
Fredrik Lindgren, CEO of Biolin Scientific, fredrik.lindgren@biolinscientific.com
| CONTACT Fredrik Lindgren CEO of BiolinScientific AB (publ) +46 705-61 61 77 fredrik.lindgren@biolinscientific.com PRODUCTS www.q-sense.com www.ksvltd.com www.nima.co.uk www.attension.com www.osstell.com | COMPANY INFORMATION BiolinScientific AB (publ) Hängpilsgatan 7 SE-426 77 Västra Frölunda Sweden Telephone: +46 31 769 7690 Fax: +46 31 69 80 40 E-mail: info@biolinscientific.com Company number: 556249-4293 Web: www.biolinscientific.com THE SHARE Nasdaq OMX Small Cap in Sweden Stock ticker: BLIN |
BIOLINSCIENTIFIC IN BRIEF
BiolinScientific is an analytical instruments provider focused on the nano-scale study of interfaces within materials research and bioscience. Our customers are scientists and researchers in academic research, research institutes and the industrial sector.